Defining suboptimal response to ruxolitinib and the strategy for switching treatments VJHemOnc – Video Journal of Hematology & HemOnc 0:53 3 months ago 56 Далее Скачать
Parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib VJHemOnc – Video Journal of Hematology & HemOnc 1:53 4 years ago 189 Далее Скачать
LIMBER-TREG108: CK0804 add-on therapy in patients with MF with suboptimal response to ruxolitinib VJHemOnc – Video Journal of Hematology & HemOnc 1:47 1 year ago 66 Далее Скачать
Inadequate or Loss of Response to Ruxolitinib and Combination Strategies in Myelofibrosis HMP Education 22:08 9 years ago 894 Далее Скачать
The promise of parsaclisib in patients with MF who have a suboptimal response to JAKi therapy VJHemOnc – Video Journal of Hematology & HemOnc 1:44 2 years ago 96 Далее Скачать
IMPROVE-MF: imetelstat and ruxolitinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:30 4 days ago 224 Далее Скачать
Interim analysis of add-on parsaclisib in myelofibrosis with suboptimal ruxolitinib response VJHemOnc – Video Journal of Hematology & HemOnc 2:33 3 years ago 48 Далее Скачать
Phase III MF studies evaluating parsaclisib + ruxolitinib in treatment naive & suboptimal responders VJHemOnc – Video Journal of Hematology & HemOnc 3:13 3 years ago 357 Далее Скачать
Inadequate or Loss of Response to Ruxolitinib, and Combination Strategies HMP Education 16:29 9 years ago 432 Далее Скачать
Add-on therapy with CK0804 for patients with MF who exhibit a suboptimal response to ruxolitinib VJHemOnc – Video Journal of Hematology & HemOnc 2:08 11 months ago 45 Далее Скачать
CK0804, a cord blood-derived cellular therapy, in myelofibrosis with suboptimal ruxolitinib response VJHemOnc – Video Journal of Hematology & HemOnc 2:54 4 months ago 138 Далее Скачать
Management of ruxolitinib failure in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:10 2 years ago 899 Далее Скачать
Update on JAK Inhibitors for Myelofibrosis: There is more than one HMP Education 25:13 8 years ago 1 096 Далее Скачать
When would you switch a patient with myelofibrosis from ruxolitinib? MPN Hub 3:19 3 years ago 122 Далее Скачать
Parsaclisib plus ruxolitinib in myelofibrosis: a promising strategy for treatment-naive patients VJHemOnc – Video Journal of Hematology & HemOnc 2:06 2 years ago 132 Далее Скачать
Phase II results of parsaclisib in patients with MF who had suboptimal responses to ruxolitinib VJHemOnc – Video Journal of Hematology & HemOnc 2:29 3 years ago 44 Далее Скачать
RESPONSE-2: 5-year follow-up of second-line ruxolitinib therapy for PV VJHemOnc – Video Journal of Hematology & HemOnc 1:32 4 years ago 83 Далее Скачать
Final results of a Phase II study of add-on parsaclisib for pts with MF and suboptimal rux response VJHemOnc – Video Journal of Hematology & HemOnc 1:07 3 months ago 52 Далее Скачать
Updated results from MANIFEST arm 2: pelabresib as add-on to ruxolitinib in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:43 1 year ago 178 Далее Скачать
